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Abstract 
Objective: The study aimed to investigate acute and sub-acute toxic potential of ethanolic extract 
of Acacia nilotica (Garad) in rats.  
Methods: LD50 of Garad was determined. Changes in behavioral response, induced by sub-acute 
treatments were recorded. Elevated urea, creatinine, ALT (GPT) and AST (GOT) in plasma were 
taken as evidence for impaired kidney and liver function.  
Results: LD50 of Garad extract was found to be 215.36 mg/kg (124.84 – 317.47). Regarding sub 
acute treatment, observations on seventh and fourteenth days showed slight to moderate sedation at 
various doses. On day 21 no behavioral changes were recorded. However, a treatment for three 
weeks induced significant elevation in urea and ALT (p < 0.05).  
Conclusion: It can be concluded that the ethanolic extract of Garad has got some toxicity when 
administered sub acutely and intraperitoneally in rats, particularly at high dose (60 mg/kg). 
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cacia nilotica , known in Sudan as 
Garad, belongs to the family fabaceae. 
It is a native species of acacia in Africa 
and the Indian subcontinent. Different parts of 
the tree are widely used in traditional 
medicine. Acacia nilotica bark is used to treat 
haemorrhage, diarrhea, dysentery and leprosy. 
The root is used for the treatment of 
tuberculosis and impotence. The bruised 
leaves are used as poultices onto ulcers. A. 
nilotica gum showed low toxicity potential in 
rats maintained on diets containing 2% and 
8% gum for two weeks1. It has been reported 
that Acacia nilotica (Linn.) gum, flower and 
leaf aqueous extracts have got 
chemopreventive activity on 7, 12-
dimethylbenz (a)anthracene (DMBA) induced 
skin papillomagenesis in male Swiss albino 
mice2. A steroid 3beta-Acetoxy-17beta-
hydroxy-androst-5-ene was isolated from 
aerial parts of Acacia nilotica (L.)3.  
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The steroid showed dose-dependent anti-
inflammatory activity against TPA (12- O 
tetradecanoylphorbol-13-acetate) induced 
mouse ear edema. The antimutagenic and 
cytotoxic effects of different extracts/fractions 
of Acacia nilotica prepared by maceration 
method were investigated. It was concluded 
that these effects, exhibited by acetone 
extract, may partially be ascribed to the 
presence of gallic acid and other 
polyphenols4. The methanolic extract of 
Acacia nilotica was observed to cause a dose-
dependent (3-30 mg/kg) fall in arterial blood 
pressure5. It has been suggested that this 
action may be mediated through calcium 
channel blockade. Survey of the existing 
knowledge has revealed that the studies on 
toxicological effects of Acacia nilotica were 
very limited; more studies are needed for 
evaluation of the toxic potential of Acacia 
nilotica, as it gains special importance to 
Sudanese patients. The specific objective of 
this study was to investigate the toxic 
potential of Garad extract sub-acute treatment 
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Materials and Methods 
Animals:  Wister SWR albino rats, 3-5 
months age, weighing 90-150g were used. 
The animals were housed in groups and kept 
under controlled conditions of room 
temperature (25+1˚C) and relative humidity 
(≈50%). Animals were fed on standard 
laboratory rodents chow and water. 
Ethanolic extract of Acacia nilotica: 
Fruits of Acacia nilotica were procured from 
Omdurman local market. Hundred grams of 
crushed seeds were washed and macerated in 
500 ml of absolute ethanol with occasional 
shaking for 2 hours and then kept overnight. 
The ethanolic extract was filtered and the 
filtrate was evaporated at room temperature. 
42 grams of the residue was then dissolved in 
a final volume of 10 ml of distilled water to 
give a stock solution of 4.2 g/ml which was 
aliquoted and kept at 4C° until used.  
LD50 determination:   
Karber's method was used6. Preliminary 
experiments were carried out for ethanolic 
extract of Acacia nilotica to determine the 
approximate doses which produced 0 – 100% 
lethality. These were found to be 75 mg/Kg 
and 500 mg/Kg, respectively. Rats were then 
divided randomly into 7 groups of 5 rats each. 
Doses of 75, 100, 112.5, 125, 187.5, 250 and 
500 mg/Kg were administered to each group 
separately. Animals were observed over the 
next 24 hours. The percentage lethality in 
each group was recorded and the LD50 was 
calculated. 
Treatment protocols for behavioral and 
hepato/ nephrotoxicity studies: 
Intraperitoneal doses of one fourth (high toxic 
dose), one eighth (medium toxic dose) and 
one sixteenth (low toxic dose) of the LD50 of 
Garad were used as described before7. Three 
sets of animals were used for each of the 
behavioral and hepato/ nephrotoxicity studies. 
Each set was formed of four groups (group 1 - 
4), five rats each. One ml/ Kg normal saline 
was administered to group 1. Ethanolic 
extract of Acacia nilotica was administered as 
60, 30 and 15 mg/ Kg to group 2, 3 and 4, 
respectively.  
For each study, the first set of animals was 
treated daily for seven days, the second set  
 
was treated daily for 14 days and the third set 
was treated daily for 21 days. 
Behavioral toxicity study:  
Changes in behavioral response, induced by 
various treatments were recorded according to 
a standard method of observation8. Effects of 
acute and sub-acute toxicities were recorded 
at 30 minutes, 1, 2 and 24 hours. 
Assessment of hepato- and nephrotoxicity:   
 Treated and control groups were 
sacrificed after 7, 14 and 21 days, 
respectively,  and plasma was obtained and 
kept at –20°C for biochemical determination 
of urea, creatinine, ALT and AST. Plasma 
elevation of urea and/or creatinine and ALT 
and/ or AST was taken as evidence for 
impaired kidney and liver functions, 
respectively9, 10.  
Statistical analysis: 
Data were expressed as mean ± SEM. 
Statistical comparisons among different 
groups were made using analysis of variance 
(ANOVA) followed by Mann-Whitney-U 
test. Significance was accepted at p < 0.05. 
Data obtained from dose/response analysis of 
acute toxicity test were calculated as 
described11.  
Results: Effects of acute doses of ethanolic 
extract of Garad on survival of rats: 
The LD50 value with 95 % CL was found to 
be: 215.36 mg/kg (124.84 – 317.47 mg/ kg), 
(Table 1). Various lethal doses caused 
difficulty in respiration, lethargy, writhing, 
spastic paralysis and coma. 
 
Table 1: Effects of acute doses of ethanolic 














No. of dead 
animals (%) 
500 5 5 (100) 
250 5 3 (60) 
187.5 5 2 (40) 
125 5 0 (0) 
112.5 5 0 (0) 
100 5 1 (20) 
75 5 0 (0) 
Tarig M. El-Hadiyah et al.                 Toxic Potential of Ethanolic Extract of Acacia nilotica (Garad)  
 
© Sudan JMS Vol. 6, No.1. Mar 2011      3 
 
Behavioral changes induced by Garad 
extract after acute treatment: 
Acute behavioral changes were recorded 
during the first 24 hours post treatment. No 
differences were noted in rats after normal 
saline injection of acute dosing at various 
time intervals. The lowest dose (15 mg/kg) of 
Garad extract induced a slight decrease of 
alertness at half an hour post treatment that 
was accompanied with a slight decrease in 
animals' spontaneous activity at 1 and 2 hours 
post treatment. A slight rise in passivity was 
also evident at 2 hours. The middle dose (30 
mg/kg) had similar effects with increased 
degree of sedative behavior at the same time 
intervals. The highest dose (60 mg/kg) gave 
more intense behavioral responses compared 
to lower doses. All these effects, regardless of 
the dose, returned to normal at 24 hours post 
treatment.  
Behavioral changes induced by Garad 
extract after sub-acute treatment: 
Sub-acute behavioral changes observations 
were taken during day 7, 14 and 21 post 
treatment at intervals of 1/2, 1 and 2 hours  
post treatment.  A circadian rhythm in 
behavioral changes was noted after the sub 
acute treatment. The 15 and 30 mg/kg doses 
induced slight decrease in locomotion at 1/2 
hour post treatment. The 60 mg/kg dose 
caused moderate inhibition of motor activity 
at 1/2 and 1 hour post treatment. At day 14, 
these doses induced less reduction in 
spontaneous activity compared to day 7. At 
day 21 there was no evidence of behavioral 
changes. 
Assessment of nephrotoxic and hepatotoxic 
potential of Garad after sub-acute treatment: 
At day 7, there was a slight decrease of urea 
with increasing dose of Garad compared to 
the control group. However, creatinine was 
slightly decreased at low and middle doses 
but returned to the control level with high 
doses of Garad. Compared to the control 
group, the AST level was significantly 
increased in the high dose group. The ALT 
showed only a slight increase in the low and 
middle dose groups but a more pronounced 
increase in the high dose group, p < 0.05 
(Table 2). 
 
Table 2: Effect of Garad on urea, creatinine, ALT and AST after 7 days treatment 
 




ALT (U /ml)) 
M±SD 
AST (U /ml) 
M±SD 
Control 34.09 ± 2.27 1.196 ± 0.134 13.6 ± 0.927 6 ± 0.837 
Low Dose  39.87 ± 1.57 1.464 ± 0.134 14.4 ± 1.661 5.4 ± 1.364 
Medium Dose 28.41 ± 1.69 1.332 ± 0.002 14.2 ± 0.374 5 ± 0.707 
High Dose  29.54 ± 4.37 1.196 ± 0.134 16 ± 0.894 10.2 ± 4.283 
 




Table 3: Effect of ethanolic extract of Garad on urea, creatinine, ALT and AST after 14 days 
treatment. 
 




ALT (IU /ml)) 
M±SD 
AST (IU /ml) 
M±SD 
Control 31.82± 4.37 1.062 ± 0.164 16 ± 1.483 7 ± 1.342 
Low Dose 28.73± 1.97 1.062 ± 0.164 13 ± 1.975 5 ± 0.837 
Medium Dose 26.36 ± 2.11 1.062 ± 0.164 15.2 ± 1.20 7 ± 1.14 
High Dose 33.18 ± 2.75 1.332 ± 0.002 19 ± 1.549 7.6 ± 0.678 
 
One way ANOVA, Tukey Kramer Multiple comparison 
Tarig M. El-Hadiyah et al.                 Toxic Potential of Ethanolic Extract of Acacia nilotica (Garad)  
 
© Sudan JMS Vol. 6, No.1. Mar 2011      4 
 
 
Table 4: Effect of ethanolic extract of Garad on urea, creatinine, ALT and AST after 21 days 
treatment. 




ALT (U /ml)) 
M±SD 
AST (U /ml) 
M±SD 
Control 17.21 ± 1.95 1.163 ± 0.168 12 ± 0.913 56.5 ± 24.85 
Low Dose 31.82 ± 9.14 1.333 ± 0.003 14 ± 0.408 28.5 ± 13.23 
Medium Dose 28.18 ± 3.1 1.196 ± 0.251 13.6 ± 0.374 29.2 ± 11.79 
High Dose 39.88 ± 1.93* 1.498 ± 0.168 15.25 ± 0.947* 44.75 ± 11.28 
 
One way ANOVA, Tukey Kramer Multiple comparison, * P<0.05, as compared to the control  
 
At day 14, the effects of Garad doses on the 
levels of urea, creatinine, ALT and AST were 
less evident compared to day 7. However, 
there was an increased level of ALT in the 
high dose group compared to the control 
group, p < 0.05 (Table 3). At day 21, there 
was a highly significant increased level of 
urea and ALT, particularly with the high 
dose, p < 0.05 (Table 4).  
 
Discussion 
Acacia nilotica is a medicinal plant that 
contains flavonoids as a major constituent. 
Flavonoids are benzo-γ-pyrone derivatives 
widespread in plants. About 4000 individual 
flavonoids have been isolated. Flavonoid 
constituents of the diet were first identified as 
vitamin P and Vitamin C, and were found to 
be important in the maintenance of capillary 
wall integrity and capillary resistance12, 13. In 
the normal diet, consumption of flavonoids is 
estimated as1g/day14. Acacia nilotica is an 
indigenous medicinal plant widely used in 
Sudan and is also common in the 
Mediterranean region15, 16. It has been shown 
to have significant hypoglycemic effects in 
rats 17, 18, and antioxidant and cytotoxic 
activities against large cell carcinoma (COR-
L23) cell line19. With all these therapeutic 
potentialities, Garad toxicity worths 
investigation. The aim of this study was to 
assess the safety of ethanolic extract of Garad 
when injected acutely intraperitoneally to rats. 
The median lethal dose (LD50) studies can 
provide valuable information on the toxicity 
of Garad. This type of study is required 
before any new compound is approved for 
testing in man. Acute treatment of rats with 
doses of 50 - 500 mg/kg ethanolic extract of 
Garad caused 20 – 100% mortality. 
According to the toxicity rating20 to our data, 
it appeared that Garad extract could be 
considered as very toxic in rats at doses of 50 
to 500 mg/kg.  
Acute dosing of Garad extract induced 
sedative effects which appeared as decreased 
spontaneous activity, decreased alertness and 
passivity. These effects were dose dependant 
and disappeared 24 hours later. After sub 
acute treatment, observations on day 7 and 14 
showed slight to moderate behavioral changes 
at various doses. On day 21 no behavioral 
changes were recorded.  There might be an 
unknown adaptive mechanism by which 
behavioral toxicity of Garad ethanolic extract 
disappears on prolonged administration. 
Numerous herbal products and herb derived 
products could cause hepatic or renal 
toxicity21. Plasma elevations of urea and 
creatinine have proved to be the most helpful 
tool in diagnosis of renal impairment, while 
elevation of ALT and AST are good indicator 
of hepatotoxic potential. In the present study 
the four parameters mentioned above did not 
show any significant change at the end of first 
and second weeks of treatment. However, 
urea and ALT increased significantly at the 
end of 21 days treatment. ALT is present 
moderately in liver but low in cardiac and 
skeletal muscle and other tissues. On the basis 
of these findings, the results of the present 
study demonstrate that Garad may have got 
sub acute toxicity. Locally, the wide use of 
Garad fruits for the traditional treatment of 
various conditions might be life threatening 
since we do not know the quantities being 
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administered in terms of mg/ kg body weight 
and the potential toxicity of this plant in 
human. We recommend further investigations 
that might offer better understanding of the 
underlying mechanisms and thus better use of 
Garad. 
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